RGS RGS Healthcare Solutions

Licence holder vs manufacturer: who really makes a generic?

Published 2026-11-04 · Updated 2026-11-17 · RGS Healthcare Solutions

Short answer: The marketing authorisation holder is the company legally responsible for a medicine in a market. The manufacturer is the company that makes and releases it. For generics they are often different: one manufacturer can supply many holders, and one holder can buy from several manufacturers, which changes who your real competitors and suppliers are.

Two different roles

The holder owns the authorisation, sets the commercial strategy and usually bids in tenders. The manufacturer produces the medicine and certifies batches for release. In generics, out-licensing and contract manufacturing make the two roles separate more often than not.

Why it matters in tenders

  1. Several bidders in one tender may be supplied by the same manufacturer.
  2. A partner can add a second supplier for your molecule without telling you.
  3. A shortage at one manufacturer can affect several holders at once.
  4. Competitor strength depends on manufacturing capacity as well as the name on the pack.

Seeing the whole chain

Linking holders, manufacturers and tender results shows the real structure of a market: who supplies whom, how much of each partner's volume is still yours, and which new holders are coming.

Questions

Is the marketing authorisation holder the manufacturer?

Not necessarily. The holder is legally responsible for the medicine; the manufacturer makes and releases it. For many generics the two are different companies.

How each market does it

Terms used in this guide

See the answer on your own molecules

We load your products and markets before the demo, and show the results for them.